Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Weiling Leng, Juan Jiang, Bing Chen & Qinan Wu. (2021) Metformin and Malignant Tumors: Not Over the Hill. Diabetes, Metabolic Syndrome and Obesity 14, pages 3673-3689.
Read now
Read now
Nahid Shahabadi, Mohammad Mahdavi & Badri Z. Momeni. (2021) Multispectroscopic analysis, atomic force microscopy, molecular docking and molecular dynamic simulation studies of the interaction between [SnMe2Cl2(Me2phen)] complex and ct-DNA in the presence of glucose. Journal of Biomolecular Structure and Dynamics 39:14, pages 5068-5082.
Read now
Read now
Ali Alhoshani, Fahad O Alatawi, Fawaz E Al-Anazi, Ibraheem M Attafi, Asad Zeidan, Abdelali Agouni, Heba M El Gamal, Licia S Shamoon, Sarah Khalaf & Hesham M Korashy. (2020) BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells. OncoTargets and Therapy 13, pages 13357-13370.
Read now
Read now
Minglei Ma, Chifa Ma, Pingping Li, Chunxiao Ma, Fan Ping, Wei Li, Lingling Xu, Huabing Zhang, Qi Sun & Yuxiu Li. (2020) Low glucose enhanced metformin’s inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p. Cell Cycle 19:17, pages 2168-2181.
Read now
Read now
Julianna M. Santos & Fazle Hussain. (2020) Higher Glucose Enhances Breast Cancer Cell Aggressiveness. Nutrition and Cancer 72:5, pages 734-746.
Read now
Read now
Meltem Cetin & Selma Sahin. (2016) Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride. Drug Delivery 23:8, pages 2796-2805.
Read now
Read now
Reema Wahdan-Alaswad, J. Chuck Harrell, Zeying Fan, Susan M. Edgerton, Bolin Liu & Ann D. Thor. (2016) Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer . Cell Cycle 15:8, pages 1046-1059.
Read now
Read now
Emily N. Chin, Joshua A. Martin, Soyoung Kim, Saja A. Fakhraldeen & Caroline M. Alexander. (2016) Lrp5 Has a Wnt-Independent Role in Glucose Uptake and Growth for Mammary Epithelial Cells. Molecular and Cellular Biology 36:6, pages 871-885.
Read now
Read now
Reema S Wahdan-Alaswad, Susan M Edgerton, Hyun Min Kim, Aik Choon Tan, Bryan R Haugen, Bolin Liu & Ann D Thor. Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast Cancer. Cell Cycle 0:0, pages 1-20.
Read now
Read now
Articles from other publishers (80)
Priya Singh, Kaushik Sen, Pratikshya Sa, Auromira Khuntia, Sunil K. Raghav, Rajeeb K. Swain & Sanjeeb Kumar Sahoo. (2023) Piperlongumine based nanomedicine impairs glycolytic metabolism in triple negative breast cancer stem cells through modulation of GAPDH & FBP1. Phytomedicine, pages 155181.
Crossref
Crossref
Nolwenn Dubois, Javier Muñoz-Garcia, Dominique Heymann & Axelle Renodon-Cornière. (2023) High glucose exposure drives intestinal barrier dysfunction by altering its morphological, structural and functional properties. Biochemical Pharmacology 216, pages 115765.
Crossref
Crossref
Samson Mathews Samuel, Elizabeth Varghese, Noothan Jyothi Satheesh, Chris R. Triggle & Dietrich Büsselberg. (2023) Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy. Biomedicine & Pharmacotherapy 164, pages 114911.
Crossref
Crossref
Brittany Baur, Junha Shin, Jacob Schreiber, Shilu Zhang, Yi Zhang, Mohith Manjunath, Jun S. Song, William Stafford Noble & Sushmita Roy. (2023) Leveraging epigenomes and three-dimensional genome organization for interpreting regulatory variation. PLOS Computational Biology 19:7, pages e1011286.
Crossref
Crossref
Yu Jin, Shuoqing Fan, Wenna Jiang, Jingya Zhang, Lexin Yang, Jiawei Xiao, Haohua An & Li Ren. (2022) Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non‐TNBC. PROTEOMICS – Clinical Applications 17:3.
Crossref
Crossref
Lingna Li, Jianing Huang, Tongmin Huang, Jie Yao, Yeyuan Zhang, Meiling Chen, Haojie Shentu & Haiying Lou. (2023) Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies. International Journal of Endocrinology 2023, pages 1-10.
Crossref
Crossref
Samaneh Mostafavi, Hamidreza Zalpoor & Zuhair Mohammad Hassan. (2022) The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors. Cellular & Molecular Biology Letters 27:1.
Crossref
Crossref
Hatice Yilmaz, Büsra Nigdelioglu, Ali Aytac, Merve Turan, Esin Oktay, Ozlem Yersal & Sabri Barutca. (2022) The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors. Future Oncology 18:27, pages 3043-3053.
Crossref
Crossref
K. O. Kuznetsov, E. R. Safina, D. V. Gaimakova, Ya. S. Frolova, I. Yu. Oganesyan, A. G. Sadertdinova, K. A. Nazmieva, A. H. Islamgulov, A. R. Karimova, A. M. Galimova & E. V. Rizvanova. (2022) Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice. Problems of Endocrinology 68:5, pages 45-55.
Crossref
Crossref
Xiangyu Meng, Zhuoxuan Lu, Qingyu Lv, Yongqiang Jiang, Liming Zhang & Zhifei Wang. (2022) Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy. Acta Biomaterialia 145, pages 222-234.
Crossref
Crossref
Mónica Cejuela, Begoña Martin-Castillo, Javier A. Menendez & Sonia Pernas. (2022) Metformin and Breast Cancer: Where Are We Now?. International Journal of Molecular Sciences 23:5, pages 2705.
Crossref
Crossref
Ga Bin Park, Jee-Yeong Jeong, Sangbong Choi, Yoo Sang Yoon & Daejin Kim. (2021) Glucose deprivation enhances resistance to paclitaxel via ELAVL2/4-mediated modification of glycolysis in ovarian cancer cells. Anti-Cancer Drugs 33:1, pages e370-e380.
Crossref
Crossref
Santosh Kumar Singh, Tejumola Apata, Shriti Singh, Melayshia McFadden & Rajesh Singh. (2021) Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer. Biomedicines 9:8, pages 1020.
Crossref
Crossref
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding & Chris R. Triggle. (2021) A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan. Frontiers in Endocrinology 12.
Crossref
Crossref
Shuang Liu, Erik V. Polsdofer, Lukun Zhou, Sanbao Ruan, Hui Lyu, Defu Hou, Hao Liu, Ann D. Thor, Zhimin He & Bolin Liu. (2021) Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC. Molecular Therapy - Oncolytics 21, pages 303-314.
Crossref
Crossref
Mohammad Erfan Zare, Atefeh Nasir Kansestani, Shahrooz Hemmati, Kamran Mansouri & Asad Vaisi-Raygani. (2021) The rate of aerobic glycolysis is a pivotal regulator of tumor progression. Journal of Diabetes & Metabolic Disorders 20:1, pages 523-531.
Crossref
Crossref
İrem Bayar & Ayşegül Bildik. (2021) Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture. Cytotechnology 73:2, pages 217-232.
Crossref
Crossref
Reema S. Wahdan-Alaswad, Susan M. Edgerton, Hiba Salem, Hyun Min Kim, Aik Choon Tan, Jessica Finlay-Schultz, Elizabeth A. Wellberg, Carol A. Sartorius, Britta M. Jacobsen, Bryan R. Haugen, Bolin Liu & Ann D. Thor. (2021) Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers. Clinical Cancer Research 27:2, pages 585-597.
Crossref
Crossref
Alicja Jagiełło, Micah Lim & Elliot Botvinick. (2020) Dermal fibroblasts and triple-negative mammary epithelial cancer cells differentially stiffen their local matrix. APL Bioengineering 4:4.
Crossref
Crossref
Kasturi Bhattacharjee, Moumita Nath & Yashmin Choudhury. (2020) Fatty acid synthesis and cancer: Aberrant expression of the ACACA and ACACB genes increases the risk for cancer. Meta Gene 26, pages 100798.
Crossref
Crossref
Maryana Teufelsbauer, Barbara Rath, Adelina Plangger, Clement Staud, Josif Nanobashvili, Ihor Huk, Christoph Neumayer, Gerhard Hamilton & Christine Radtke. (2020) Effects of metformin on adipose-derived stromal cell (ADSC) – Breast cancer cell lines interaction. Life Sciences 261, pages 118371.
Crossref
Crossref
Zeyun Gao, Mongameli B. Dlamini, Hong Ge, Liping Jiang, Chengyan Geng, Qiujuan Li, Xiaoxia Shi, Yong Liu & Jun Cao. (2020) ATF4-mediated autophagy-dependent glycolysis plays an important role in attenuating apoptosis induced by Cr (VI) in A549 cells. Toxicology Letters 331, pages 178-187.
Crossref
Crossref
Assunta Sellitto, Ylenia D’Agostino, Elena Alexandrova, Jessica Lamberti, Giovanni Pecoraro, Domenico Memoli, Domenico Rocco, Elena Coviello, Giorgio Giurato, Giovanni Nassa, Roberta Tarallo, Alessandro Weisz & Francesca Rizzo. (2020) Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer. Cancers 12:6, pages 1477.
Crossref
Crossref
José Antonio Jara, Diego Rojas, Vicente Castro-Castillo, Sebastián Fuentes-Retamal, Cristian Sandoval-Acuña, Eduardo Parra, Mario Pavani, Juan Diego Maya, Jorge Ferreira & Mabel Catalán. (2020) Novel benzoate-lipophilic cations selectively induce cell death in human colorectal cancer cell lines. Toxicology in Vitro 65, pages 104814.
Crossref
Crossref
Hao Wang, Lidong Zhao, Jing Wu, Jiang Hong & Songpo Wang. (2020) Propofol induces ROS‑mediated intrinsic apoptosis and migration in triple‑negative breast cancer cells. Oncology Letters 20:1, pages 810-816.
Crossref
Crossref
Ida Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, Sushma Bartaula-Brevik, Tor Henrik Tvedt, Øystein Bruserud & Kimberley Joanne Hatfield. (2020) Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity. Cells 9:5, pages 1155.
Crossref
Crossref
Wojciech Wojtowicz, Anna Wróbel, Karolina Pyziak, Radosław Tarkowski, Alicja Balcerzak, Marek Bębenek & Piotr Młynarz. (2020) Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles. Metabolites 10:5, pages 173.
Crossref
Crossref
Anindita De & Gowthamarajan Kuppusamy. (2020) Metformin in breast cancer: preclinical and clinical evidence. Current Problems in Cancer 44:1, pages 100488.
Crossref
Crossref
Rui Xu, Junhao You, Fang Li & Bing Yan. (2020) Postoperative Fasting Blood Glucose Predicts Prognosis in Stage I-III Colorectal Cancer Patients Undergoing Resection. Gastroenterology Research and Practice 2020, pages 1-7.
Crossref
Crossref
Reema S. Wahdan-Alaswad & Ann D. Thor. 2020. Metformin [Working Title]. Metformin [Working Title].
Harras J. Khan, Sagar O. Rohondia, Zainab Sabry Othman Ahmed, Nirav Zalavadiya & Q. Ping Dou. 2020. Drug Repurposing in Cancer Therapy. Drug Repurposing in Cancer Therapy
121
172
.
Claudia Tanja MierkeClaudia Tanja Mierke. 2020. Cellular Mechanics and Biophysics. Cellular Mechanics and Biophysics
825
891
.
Samson Samuel, Elizabeth Varghese, Peter Kubatka, Chris Triggle & Dietrich Büsselberg. (2019) Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer. Biomolecules 9:12, pages 846.
Crossref
Crossref
Samson Mathews Samuel, Noothan Jyothi Satheesh, Suparna Ghosh, Dietrich Büsselberg, Yasser Majeed, Hong Ding & Chris R. Triggle. (2019) Treatment with a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy. Cancers 11:11, pages 1737.
Crossref
Crossref
Jonathan Navarro, Incheon Kang, Ho Kyoung Hwang, Dong Sup Yoon, Woo Jung Lee & Chang Moo Kang. (2019) Glucose to Lymphocyte Ratio as a Prognostic Marker in Patients With Resected pT2 Gallbladder Cancer. Journal of Surgical Research 240, pages 17-29.
Crossref
Crossref
Hans-Juergen Schulten & Sherin Bakhashab. (2019) Meta-Analysis of Microarray Expression Studies on Metformin in Cancer Cell Lines. International Journal of Molecular Sciences 20:13, pages 3173.
Crossref
Crossref
Zhiguang Xiao, Bianca Sperl, Silvia Gärtner, Tatiana Nedelko, Elvira Stacher-Priehse, Axel Ullrich & Pjotr G. Knyazev. (2019) Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach. Oncotarget 10:26, pages 2546-2560.
Crossref
Crossref
Sharon Varghese, Samson Mathews Samuel, Elizabeth Varghese, Peter Kubatka & Dietrich Büsselberg. (2019) High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells. Biomolecules 9:1, pages 16.
Crossref
Crossref
Mohsin HK Roshan, Yan K Shing & Nikolai P Pace. (2019) Metformin as an adjuvant in breast cancer treatment. SAGE Open Medicine 7, pages 205031211986511.
Crossref
Crossref
Eylem Kulkoyluoglu-Cotul, Alexandra Arca & Zeynep Madak-Erdogan. (2019) Crosstalk between Estrogen Signaling and Breast Cancer Metabolism. Trends in Endocrinology & Metabolism 30:1, pages 25-38.
Crossref
Crossref
Samson Mathews Samuel, Elizabeth Varghese, Sharon Varghese & Dietrich Büsselberg. (2018) Challenges and perspectives in the treatment of diabetes associated breast cancer. Cancer Treatment Reviews 70, pages 98-111.
Crossref
Crossref
Biplab Giri, Sananda Dey, Tanaya Das, Mrinmoy Sarkar, Jhimli Banerjee & Sandeep Kumar Dash. (2018) Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomedicine & Pharmacotherapy 107, pages 306-328.
Crossref
Crossref
Hans-Juergen Schulten. (2018) Pleiotropic Effects of Metformin on Cancer. International Journal of Molecular Sciences 19:10, pages 2850.
Crossref
Crossref
Andréia Vasconcelos-dos-Santos, Rafaela Muniz de Queiroz, Bruno da Costa Rodrigues, Adriane R. Todeschini & Wagner B. Dias. (2018) Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression. Journal of Bioenergetics and Biomembranes 50:3, pages 175-187.
Crossref
Crossref
Lisa D. Kellenberger & Jim Petrik. (2018) Hyperglycemia promotes insulin-independent ovarian tumor growth. Gynecologic Oncology 149:2, pages 361-370.
Crossref
Crossref
Vineela Chukkapalli, Leo I. Gordon, Parameswaran Venugopal, Jeffrey A. Borgia & Reem Karmali. (2018) Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells. Oncotarget 9:30, pages 21166-21181.
Crossref
Crossref
Ying Li, Meng Wang, Pei Zhi, Jian You & Jian-Qing Gao. (2017) Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models. Oncotarget 9:2, pages 2158-2174.
Crossref
Crossref
Rubí Viedma-Rodríguez, María Guadalupe Martínez-Hernández, Luis Antonio Flores-López & Luis Arturo Baiza-Gutman. (2017) Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system. Molecular and Cellular Biochemistry 437:1-2, pages 65-80.
Crossref
Crossref
Nathan J. Lanning, Joshua P. Castle, Simar J. Singh, Andre N. Leon, Elizabeth A. Tovar, Amandeep Sanghera, Jeffrey P. MacKeigan, Fabian V. Filipp & Carrie R. Graveel. (2017) Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities. Cancer & Metabolism 5:1.
Crossref
Crossref
Su Yon Jung, Eric M. Sobel, Jeanette C. Papp & Zuo-Feng Zhang. (2017) Effect of genetic variants and traits related to glucose metabolism and their interaction with obesity on breast and colorectal cancer risk among postmenopausal women. BMC Cancer 17:1.
Crossref
Crossref
Gerke Ariaans, Mathilde Jalving, Emma Geertruida Elisabeth de Vries & Steven de Jong. (2017) Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells. BMC Cancer 17:1.
Crossref
Crossref
Lobna Al-Zaidan, Rasha Abu El Ruz & Ahmed M. Malki. (2017) Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach. Frontiers in Public Health 5.
Crossref
Crossref
Jihae Shin, Ki Young Paek, Maria Ivshina, Emily E. Stackpole & Joel D. Richter. (2017) Essential role for non-canonical poly(A) polymerase GLD4 in cytoplasmic polyadenylation and carbohydrate metabolism. Nucleic Acids Research 45:11, pages 6793-6804.
Crossref
Crossref
Elena Strekalova, Dmitry Malin, Harisha Rajanala & Vincent L. Cryns. (2017) Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression. Breast Cancer Research and Treatment 163:3, pages 435-447.
Crossref
Crossref
Arjun P. Athreya, Krishna R. Kalari, Junmei Cairns, Alan J. Gaglio, Quin F. Wills, Nifang Niu, Richard Weinshilboum, Ravishankar K. Iyer & Liewei Wang. (2017) Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer. Oncotarget 8:16, pages 27199-27215.
Crossref
Crossref
Peiguo Shi, Wenjing Liu, Tala, Haixia Wang, Fubing Li, Hailin Zhang, Yingying Wu, Yanjie Kong, Zhongmei Zhou, Chunyan Wang, Wenlin Chen, Rong Liu & Ceshi Chen. (2017) Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation. Cell Discovery 3:1.
Crossref
Crossref
Francesca Sacco, Alberto Calderone, Luisa Castagnoli & Gianni Cesareni. (2016) The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug. British Journal of Cancer 115:12, pages 1451-1456.
Crossref
Crossref
Archana Bhaw-Luximon & Dhanjay Jhurry. (2016) Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification. Journal of Cancer Research and Clinical Oncology 142:10, pages 2159-2171.
Crossref
Crossref
Javier A. Menendez, Begoña Martin-Castillo & Jorge Joven. (2016)
Metformin and cancer:
Quo vadis et cui bono?
. Oncotarget 7:34, pages 54096-54101.
Crossref
Crossref
Rafał Krętowski, Małgorzata Borzym-Kluczyk, Anna Stypułkowska, Justyna Brańska-Januszewska, Halina Ostrowska & Marzanna Cechowska-Pasko. (2016) Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells. Molecular and Cellular Biochemistry 417:1-2, pages 35-47.
Crossref
Crossref
Maruša Rajh, Klemen Dolinar, Katarina Miš, Mojca Pavlin & Sergej Pirkmajer. (2016) Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells. PLOS ONE 11:5, pages e0154747.
Crossref
Crossref
Lian-Wen Yuan. (2016) Glucose metabolism in gastric cancer: The cutting-edge. World Journal of Gastroenterology 22:6, pages 2046.
Crossref
Crossref
Athanasios Bikas, Kirk Jensen, Aneeta Patel, John Costello, Dennis McDaniel, Joanna Klubo-Gwiezdzinska, Olexander Larin, Victoria Hoperia, Kenneth D Burman, Lisa Boyle, Leonard Wartofsky & Vasyl Vasko. (2015) Glucose-deprivation increases thyroid cancer cells sensitivity to metformin. Endocrine-Related Cancer 22:6, pages 919-932.
Crossref
Crossref
Lacey M. Litchfield, Abir Mukherjee, Mark A. Eckert, Alyssa Johnson, Kathryn A. Mills, Shawn Pan, Viji Shridhar, Ernst Lengyel & Iris L. Romero. (2015) Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer. Oncotarget 6:27, pages 23548-23560.
Crossref
Crossref
Alessandra Silvestri, Francesco Palumbo, Ignazio Rasi, Daniela Posca, Theodora Pavlidou, Serena Paoluzi, Luisa Castagnoli & Giovanni Cesareni. (2015) Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions. PLOS ONE 10:8, pages e0136250.
Crossref
Crossref
Laura Pizzuti, Patrizia Vici, Luigi Di Lauro, Domenico Sergi, Marina Della Giulia, Paolo Marchetti, Marcello Maugeri-Saccà, Antonio Giordano & Maddalena Barba. (2015) Metformin and breast cancer: Basic knowledge in clinical context. Cancer Treatment Reviews 41:5, pages 441-447.
Crossref
Crossref
Zaid H. Maayah, Hazem Ghebeh, Abdulqader A. Alhaider, Ayman O.S. El-Kadi, Anatoly A. Soshilov, Michael S. Denison, Mushtaq Ahmad Ansari & Hesham M. Korashy. (2015) Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway. Toxicology and Applied Pharmacology 284:2, pages 217-226.
Crossref
Crossref
Lev M Berstein, Dmitry A Vasilyev, Aglaya G Iyevleva, Marina P Boyarkina, Tatyana E Poroshina, Angela S Khadzhimba & Evgeny N Imyanitov. (2015) Potential and real ‘antineoplastic’ and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females. Future Oncology 11:5, pages 759-770.
Crossref
Crossref
D. S. Novikova, A. V. Garabadzhiu, G. Melino, N. A. Barlev & V. G. Tribulovich. (2015) AMP-activated protein kinase: Structure, function, and role in pathological processes. Biochemistry (Moscow) 80:2, pages 127-144.
Crossref
Crossref
Jason C. Tung, J. Matthew Barnes, Shraddha R. Desai, Christopher Sistrunk, Matthew W. Conklin, Pepper Schedin, Kevin W. Eliceiri, Patricia J. Keely, Victoria L. Seewaldt & Valerie M. Weaver. (2015) Tumor mechanics and metabolic dysfunction. Free Radical Biology and Medicine 79, pages 269-280.
Crossref
Crossref
Diana Hatoum & Eileen M. McGowan. (2015) Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?. BioMed Research International 2015, pages 1-13.
Crossref
Crossref
Barbara Salani, Alberto Del Rio, Cecilia Marini, Gianmario Sambuceti, Renzo Cordera & Davide Maggi. (2014) Metformin, cancer and glucose metabolism. Endocrine-Related Cancer 21:6, pages R461-R471.
Crossref
Crossref
Elizabeth A. Wellberg & Steven M. Anderson. (2014) FASNating Targets of Metformin in Breast Cancer Stem-Like Cells. Hormones and Cancer 5:6, pages 358-362.
Crossref
Crossref
Reema S. Wahdan-Alaswad, Dawn R. Cochrane, Nicole S. Spoelstra, Erin N. Howe, Susan M. Edgerton, Steven M. Anderson, Ann D. Thor & Jennifer K. Richer. (2014) Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b. Hormones and Cancer 5:6, pages 374-389.
Crossref
Crossref
Marta Gritti, Roberto Würth, Marina Angelini, Federica Barbieri, Marta Peretti, Erika Pizzi, Alessandra Pattarozzi, Elisa Carra, Rodolfo Sirito, Antonio Daga, Paul M.G. Curmi, Michele Mazzanti & Tullio Florio. (2014) Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current. Oncotarget 5:22, pages 11252-11268.
Crossref
Crossref
Achilleas G. Mitrakas, Dimitra Kalamida & Michael I. Koukourakis. (2014) Effect of mitochondrial metabolism-interfering agents on cancer cell mitochondrial function and radio/chemosensitivity. Anti-Cancer Drugs 25:10, pages 1182-1191.
Crossref
Crossref
Andre-R. Rotmann, Steffen Wagner, Heiko Hofmann & Johannes F. Coy. (2014) TKTL1 — Schlüsselenzym in der Onkologie. gynäkologie + geburtshilfe 19:2, pages 60-62.
Crossref
Crossref
Lev Mikhaylovich Bershteyn, Dmitriy Alexeevich Vasil'ev, Aglaya Gennadievna Ievleva, Tatiana Evgen'evna Poroshina & Evgeny Naumovich Imyanitov. (2014) Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer. Diabetes mellitus 17:1, pages 21-28.
Crossref
Crossref
Wanxing Duan, Xin Shen, Jianjun Lei, Qinhong Xu, Yongtian Yu, Rong Li, Erxi Wu & Qingyong Ma. (2014) Hyperglycemia, a Neglected Factor during Cancer Progression. BioMed Research International 2014, pages 1-10.
Crossref
Crossref
Xiangyu Meng, Zhuoxuan Lu, Qingyu Lv, Yongqiang Jiang, Liming Zhang & Zhifei Wang. (2022) Tumor Metabolism Destruction Via Metformin-Based Glycolysis Inhibition and Glucose Oxidase-Mediated Glucose Deprivation for Enhanced Cancer Therapy. SSRN Electronic Journal.
Crossref
Crossref